{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:54:53Z","timestamp":1792155293039,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100015691","name":"Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068633"],"award-info":[{"award-number":["UM1AI068633"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068615"],"award-info":[{"award-number":["UM1AI068615"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI106707"],"award-info":[{"award-number":["UM1AI106707"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s10461-024-04463-3","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T13:02:42Z","timestamp":1724072562000},"page":"3873-3882","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of the Dapivirine Vaginal Ring Accounting for Imperfect Adherence"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7032-6944","authenticated-orcid":false,"given":"Marla J.","family":"Husnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Heffron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbra","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"van der Straten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thesla","family":"Palanee-Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Soto-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devika","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda Gati","family":"Mirembe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Livant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakir","family":"Gaffoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila E.","family":"Mansoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha S.","family":"Siva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufia","family":"Dadabhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia Matovu","family":"Kiweewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared M.","family":"Baeten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the MTN-020\/ASPIRE Study Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,19]]},"reference":[{"key":"4463_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367:399\u2013410.","journal-title":"N Engl J Med"},{"key":"4463_CR2","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","volume":"381","author":"K Choopanya","year":"2013","unstructured":"Choopanya K, Martin M, Suntharasamai P, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381:2083\u201390.","journal-title":"Lancet"},{"key":"4463_CR3","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant RM, Lama JR, Anderson PL, et al. Pre-exposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587\u201399.","journal-title":"N Engl J Med"},{"key":"4463_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","volume":"372","author":"JM Marrazzo","year":"2015","unstructured":"Marrazzo JM, Ramjee G, Richardson BA, et al. Tenofovir based pre-exposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372:509\u201318.","journal-title":"N Engl J Med"},{"issue":"5","key":"4463_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","volume":"367","author":"L Van Damme","year":"2012","unstructured":"Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411\u201322.","journal-title":"N Engl J Med"},{"issue":"11","key":"4463_CR6","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S1473-3099(18)30428-6","volume":"18","author":"S Delany-Moretlwe","year":"2018","unstructured":"Delany-Moretlwe S, Lombard C, Baron D, Bekker LG, Nkala B, Ahmed K, Sebe M, Brumskine W, Nchabeleng M, Palanee-Philips T, Ntshangase J, Sibiya S, Smith E, Panchia R, Myer L, Schwartz JL, Marzinke M, Morris L, Brown ER, Doncel GF, Gray G, Rees H. Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2018;18(11):1241\u201350.","journal-title":"Lancet Infect Dis"},{"key":"4463_CR7","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","volume":"375","author":"JM Baeten","year":"2016","unstructured":"Baeten JM, Palanee-Phillips T, Brown ER, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med. 2016;375:2121\u201332.","journal-title":"N Engl J Med"},{"issue":"4","key":"4463_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1503\/cmaj.051625","volume":"175","author":"CE Hewitt","year":"2006","unstructured":"Hewitt CE, Torgerson DJ, Miles JN. Is there another way to take account of noncompliance in randomized controlled trials? Can Med Assoc J. 2006;175(4):347.","journal-title":"Can Med Assoc J"},{"issue":"6","key":"4463_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128857","volume":"10","author":"T Palanee-Phillips","year":"2015","unstructured":"Palanee-Phillips T, Schwartz K, Brown ER, et al. Characteristics of women enrolled into a randomized clinical trial of dapivirine vaginal ring for HIV-1 prevention. PLoS ONE. 2015;10(6): e0128857. https:\/\/doi.org\/10.1371\/journal.pone.0128857.","journal-title":"PLoS ONE"},{"key":"4463_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jpba.2016.03.023","volume":"125","author":"P Spence","year":"2016","unstructured":"Spence P, Nel A, van Niekerk N, et al. Post-use assay of vaginal rings (VRs) as a potential measure of clinical trial adherence. J Pharm Biomed Anal. 2016;125:94\u2013100.","journal-title":"J Pharm Biomed Anal"},{"issue":"10","key":"4463_CR11","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1097\/QAD.0000000000000280","volume":"28","author":"A Nel","year":"2014","unstructured":"Nel A, Haazen W, Nuttall J, et al. A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women. AIDS. 2014;28(10):1479\u201387.","journal-title":"AIDS"},{"key":"4463_CR12","first-page":"355","volume":"5","author":"AM Nel","year":"2014","unstructured":"Nel AM, Haazen W, Nuttall J, Romano JP, Mesquita PM, Herold BC, Rosenberg ZF, Niekerk NV. Pharmacokinetics and safety assessment of anti-HIV dapivirine vaginal microbicide rings with multiple dosing. J AIDS Clin Res. 2014;5:355.","journal-title":"J AIDS Clin Res"},{"key":"4463_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147743","volume":"11","author":"A Nel","year":"2016","unstructured":"Nel A, Bekker LG, Bukusi E, et al. Safety, acceptability and adherence of dapivirine vaginal ring in a microbicide clinical trial conducted in multiple countries in sub-Saharan Africa. PLoS ONE. 2016;11: e0147743.","journal-title":"PLoS ONE"},{"key":"4463_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/jia2.25634","volume":"23","author":"ER Brown","year":"2020","unstructured":"Brown ER, Hendrix CW, van der Straten A, et al. Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV-1 acquisition: a secondary analysis from a randomized, placebo-controlled trial. J Int AIDS Soc. 2020;23:11.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"4463_CR15","first-page":"28","volume":"7","author":"TJ Van der Weele","year":"2011","unstructured":"Van der Weele TJ. Principal stratification\u2014uses and limitations. Int J Biostat. 2011;7(1):28.","journal-title":"Int J Biostat"},{"issue":"1","key":"4463_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.0006-341X.2002.00021.x","volume":"58","author":"CE Frangakis","year":"2002","unstructured":"Frangakis CE, Rubin DB. Principal stratification in causal inference. Biometrics. 2002;58(1):21\u20139.","journal-title":"Biometrics"},{"key":"4463_CR17","unstructured":"Shtatland E, Kleinman K, Cain E. Stepwise Methods in Using SAS PROC LOGISTIC and SAS Enterprise Miner for Prediction. In: SUGI'28 Proceedings; 2003."},{"issue":"452","key":"4463_CR18","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1080\/01621459.2000.10474306","volume":"95","author":"DA Follmann","year":"2000","unstructured":"Follmann DA. On the effect of treatment among treatment compliers: an analysis of the Multiple Risk Factor Intervention Trial. J Am Stat Assoc. 2000;95(452):1101\u20139.","journal-title":"J Am Stat Assoc"},{"issue":"6","key":"4463_CR19","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/aje\/kwn164","volume":"168","author":"SR Cole","year":"2008","unstructured":"Cole SR, Hern\u00e1n MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168(6):656\u201364.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"4463_CR20","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","volume":"11","author":"JM Robins","year":"2000","unstructured":"Robins JM, Hern\u00e1n MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11(5):550\u201360.","journal-title":"Epidemiology"},{"issue":"3","key":"4463_CR21","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/j.0006-341X.2000.00779.x","volume":"56","author":"JM Robins","year":"2000","unstructured":"Robins JM, Finkelstein DM. Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics. 2000;56(3):779\u201388.","journal-title":"Biometrics"},{"issue":"7","key":"4463_CR22","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1136\/jech.2004.029496","volume":"60","author":"MA Hern\u00e1n","year":"2006","unstructured":"Hern\u00e1n MA, Robins JM. Estimating causal effects from epidemiological data. J Epidemiol Community Health. 2006;60(7):578\u201386.","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"4463_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cmpb.2003.10.004","volume":"75","author":"SR Cole","year":"2004","unstructured":"Cole SR, Hern\u00e1n M. Adjusted survival curves with inverse probability weights. Comput Methods Programs Biomed. 2004;75(1):45\u20139.","journal-title":"Comput Methods Programs Biomed"},{"key":"4463_CR24","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1037\/h0037350","volume":"56","author":"DB Rubin","year":"1974","unstructured":"Rubin DB. Estimating causal effects of treatments in randomized and nonrandomized studies. J Educ Psychol. 1974;56:688\u2013701.","journal-title":"J Educ Psychol"},{"issue":"3","key":"4463_CR25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/ije\/15.3.413","volume":"15","author":"S Greenland","year":"1986","unstructured":"Greenland S, Robins JM. Identifiability, exchangeability, and epidemiological confounding. Int J Epidemiol. 1986;15(3):413\u20139.","journal-title":"Int J Epidemiol"},{"key":"4463_CR26","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/QAI.0000000000001503","volume":"76","author":"MJ Husnik","year":"2017","unstructured":"Husnik MJ, Brown ER, Marzinke M, et al. Implementation of a novel adherence monitoring strategy in a phase III, blinded, placebo-controlled, HIV-1 prevention clinical trial. J Acquir Immune Defic Syndr. 2017;76:330\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"4463_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/EDE.0b013e31818ef366","volume":"20","author":"SR Cole","year":"2009","unstructured":"Cole SR, Frangakis CE. The consistency statement in causal inference: a definition or an assumption? Epidemiology. 2009;20(1):3\u20135.","journal-title":"Epidemiology"},{"issue":"8","key":"4463_CR28","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/QAD.0000000000001452","volume":"31","author":"ET Montgomery","year":"2017","unstructured":"Montgomery ET, van der Straten A, Chitukuta M, et al. Acceptability and use of a dapivirine vaginal ring in a phase III trial. AIDS. 2017;31(8):1159\u201367.","journal-title":"AIDS"},{"key":"4463_CR29","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s10461-012-0248-4","volume":"7","author":"ET Montgomery","year":"2012","unstructured":"Montgomery ET, van der Straten A, Cheng H, Wegner L, Masenga G, von Mollendorf C, et al. Vaginal ring adherence in sub-Saharan Africa: expulsion, removal, and perfect use. AIDS Behav. 2012;7:1787\u201398.","journal-title":"AIDS Behav"},{"key":"4463_CR30","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/s10461-012-0215-0","volume":"16","author":"A van der Straten","year":"2012","unstructured":"van der Straten A, Montgomery E, Cheng H, Wegner L, Masenga G, von Mollendorf C, et al. High acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in African women. AIDS Behav. 2012;16:1775\u201386.","journal-title":"AIDS Behav"},{"issue":"11","key":"4463_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224898","volume":"14","author":"JB Griffin","year":"2019","unstructured":"Griffin JB, Ridgeway K, Montgomery E, Torjesen K, Clark R, Peterson J, et al. Vaginal ring acceptability and related preferences among women in low- and middle-income countries: a systematic review and narrative synthesis. PLoS ONE. 2019;14(11): e0224898.","journal-title":"PLoS ONE"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-024-04463-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-024-04463-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-024-04463-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T02:06:16Z","timestamp":1728871576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-024-04463-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["4463"],"URL":"https:\/\/doi.org\/10.1007\/s10461-024-04463-3","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,19]]},"assertion":[{"value":"2 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JMB is an employee of Gilead Sciences\u00a0outside of the\u00a0present work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}